IRIS Accounts Production v26.1.10.61 07983476 Board of Directors 1.12.23 30.11.24 30.11.24 7/7/2026 false true false false true false Auditors Opinion Ordinary shares 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 07983476 2023-11-30 07983476 2024-11-30 07983476 2023-12-01 2024-11-30 07983476 2022-11-30 07983476 2022-12-01 2023-11-30 07983476 2023-11-30 07983476 ns15:EnglandWales 2023-12-01 2024-11-30 07983476 ns14:PoundSterling 2023-12-01 2024-11-30 07983476 ns10:Director1 2023-12-01 2024-11-30 07983476 ns10:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 07983476 ns10:SmallEntities 2023-12-01 2024-11-30 07983476 ns10:Audited 2023-12-01 2024-11-30 07983476 ns10:SmallCompaniesRegimeForDirectorsReport 2023-12-01 2024-11-30 07983476 ns10:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 07983476 ns10:FullAccounts 2023-12-01 2024-11-30 07983476 ns10:OrdinaryShareClass1 2023-12-01 2024-11-30 07983476 ns10:Director3 2023-12-01 2024-11-30 07983476 ns10:RegisteredOffice 2023-12-01 2024-11-30 07983476 ns5:CurrentFinancialInstruments 2024-11-30 07983476 ns5:CurrentFinancialInstruments 2023-11-30 07983476 ns5:Non-currentFinancialInstruments 2024-11-30 07983476 ns5:Non-currentFinancialInstruments 2023-11-30 07983476 ns5:ShareCapital 2024-11-30 07983476 ns5:ShareCapital 2023-11-30 07983476 ns5:RetainedEarningsAccumulatedLosses 2024-11-30 07983476 ns5:RetainedEarningsAccumulatedLosses 2023-11-30 07983476 ns5:PlantMachinery 2023-11-30 07983476 ns5:FurnitureFittings 2023-11-30 07983476 ns5:ComputerEquipment 2023-11-30 07983476 ns5:PlantMachinery 2023-12-01 2024-11-30 07983476 ns5:FurnitureFittings 2023-12-01 2024-11-30 07983476 ns5:ComputerEquipment 2023-12-01 2024-11-30 07983476 ns5:PlantMachinery 2024-11-30 07983476 ns5:FurnitureFittings 2024-11-30 07983476 ns5:ComputerEquipment 2024-11-30 07983476 ns5:PlantMachinery 2023-11-30 07983476 ns5:FurnitureFittings 2023-11-30 07983476 ns5:ComputerEquipment 2023-11-30 07983476 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-11-30 07983476 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2023-11-30 07983476 ns5:CurrentFinancialInstruments 2023-12-01 2024-11-30 07983476 ns5:Non-currentFinancialInstruments ns5:BetweenOneTwoYears 2024-11-30 07983476 ns5:Non-currentFinancialInstruments ns5:BetweenOneTwoYears 2023-11-30 07983476 ns5:Non-currentFinancialInstruments ns5:BetweenTwoFiveYears 2024-11-30 07983476 ns5:Non-currentFinancialInstruments ns5:BetweenTwoFiveYears 2023-11-30 07983476 ns10:OrdinaryShareClass1 2024-11-30

REGISTERED NUMBER: 07983476 (England and Wales)

CRAWSHAW HALL HEALTHCARE LIMITED

Financial Statements for the Year Ended 30 November 2024

CRAWSHAW HALL HEALTHCARE LIMITED (REGISTERED NUMBER: 07983476)

Contents of the Financial Statements

for the Year Ended 30 November 2024

Page |

| Company Information | 1 |

| Statement of Financial Position | 2 |

| Notes to the Financial Statements | 3 |

CRAWSHAW HALL HEALTHCARE LIMITED

Company Information

for the Year Ended 30 November 2024

| DIRECTORS: | Anthony George Kingston Massouras

| Emily Jane Whitehurst

| REGISTERED OFFICE: | 491a Bradford Road

| Batley

| West Yorkshire

| WF17 8LQ

| REGISTERED NUMBER: | 07983476 (England and Wales)

| INDEPENDENT AUDITORS: | Cooper Parry Audit (Ireland) Limited

| Statutory Auditor

| Unit 7 Dyehouse

| Linen Green

| Dungannon

| Co. Tyrone

| BT71 7HB

CRAWSHAW HALL HEALTHCARE LIMITED (REGISTERED NUMBER: 07983476)

Statement of Financial Position

30 November 2024

| 2024 |  | 2023

| Notes | £ | £ |

NON-CURRENT ASSETS

Tangible assets | 5 | 576,162 |  | 579,948 |  |

CURRENT ASSETS

Stocks | 2,525 |  | 2,525 |  |

Receivables: amounts falling due within one year | 6 | 3,220,660 |  | 2,300,892 |  |

Cash at bank and in hand | 207,923 |  | 69,218 |  |

3,431,108 |  | 2,372,635 |  |

PAYABLES

Amounts falling due within one year | 7 | (1,215,213 | ) | (1,482,549 | ) |

NET CURRENT ASSETS | 2,215,895 |  | 890,086 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 2,792,057 |  | 1,470,034 |  |

PAYABLES

Amounts falling due after more than one year | 8 | (100,000 | ) | - |  |

NET ASSETS | 2,692,057 |  | 1,470,034 |  |

CAPITAL AND RESERVES

Called up share capital | 10 | 4 |  | 4 |  |

Retained earnings | 2,692,053 |  | 1,470,030 |  |

SHAREHOLDERS' FUNDS | 2,692,057 |  | 1,470,034 |  |

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 July 2026 and were signed on its behalf by:

Anthony George Kingston Massouras - Director

CRAWSHAW HALL HEALTHCARE LIMITED (REGISTERED NUMBER: 07983476)

Notes to the Financial Statements

for the Year Ended 30 November 2024

1. | STATUTORY INFORMATION

| Crawshaw Hall Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | STATEMENT OF COMPLIANCE

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| The financial statements have been prepared under the historical cost convention.

| The accounts are prepared under the historical cost convention modified when necessary to include the revaluation of certain fixed assets.

| Revenue

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Property, plant and equipment

| Depreciation is provided at the following annual rates in order to write off each asset over its

| estimated useful life.

| Depreciation is provided at the following annual rates in order to write off each asset over its

| estimated useful life or, if held under a finance lease, over the lease term, whichever is the

| shorter.

| Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. Historical cost included expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

| The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:

| Office equipment |  | 20% reducing balance |  |

| Fixtures and fittings |  | 10% - 20% reducing balance |  |

| Computer equipment |  | 25% reducing balance |  |

| The carrying values of property, plant and equipment are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

| Inventories

| Stocks are valued at the lower of cost and net realisable value. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition. Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

CRAWSHAW HALL HEALTHCARE LIMITED (REGISTERED NUMBER: 07983476)

Notes to the Financial Statements - continued

for the Year Ended 30 November 2024

3. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Cash flow statement

| The company has availed of the exemption in FRS 102 Section 1A from the requirement to prepare a Statement of Cash Flows because it is classified as a small company.

4. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 105 (2023 - 82 ) .

5. | PROPERTY, PLANT AND EQUIPMENT

| Fixtures |

| Office |  | and |  | Computer |

| equipment |  | fittings |  | equipment |  | Totals

£ | £ | £ | £ |

| COST

| At 1 December 2023 | 41,472 |  | 1,042,340 |  | 10,000 |  | 1,093,812 |  |

| Additions | 849 |  | 60,835 |  | 5,777 |  | 67,461 |  |

| At 30 November 2024 | 42,321 |  | 1,103,175 |  | 15,777 |  | 1,161,273 |  |

| DEPRECIATION

| At 1 December 2023 | 14,788 |  | 495,744 |  | 3,332 |  | 513,864 |  |

| Charge for year | 5,436 |  | 63,316 |  | 2,495 |  | 71,247 |  |

| At 30 November 2024 | 20,224 |  | 559,060 |  | 5,827 |  | 585,111 |  |

| NET BOOK VALUE

| At 30 November 2024 | 22,097 |  | 544,115 |  | 9,950 |  | 576,162 |  |

| At 30 November 2023 | 26,684 |  | 546,596 |  | 6,668 |  | 579,948 |  |

6. | RECEIVABLES: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Trade debtors | 863,878 |  | 355,269 |  |

| Amounts owed by group undertakings | 1,002,771 |  | 1,024,707 |  |

| Amounts owed by associates | 1,329,996 |  | 907,711 |  |

| Other debtors | 24,015 |  | 13,205 |  |

3,220,660 |  | 2,300,892 |  |

CRAWSHAW HALL HEALTHCARE LIMITED (REGISTERED NUMBER: 07983476)

Notes to the Financial Statements - continued

for the Year Ended 30 November 2024

6. | RECEIVABLES: AMOUNTS FALLING DUE WITHIN ONE YEAR - continued

| Amounts owed by group undertakings and associates are interest free and payable on demand.

7. | PAYABLES: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Bank loans and overdrafts (see note 9) | 40,000 |  | 62,500 |  |

| Trade payables | 106,051 |  | 90,661 |  |

| Amounts owed to associates | 246,607 |  | 649,099 |  |

| Taxation and social security | 360,043 |  | 526,549 |  |

| Other payables | 462,512 |  | 153,740 |  |

1,215,213 |  | 1,482,549 |  |

| Amounts owed to associates are interest free and repayable on demand.

8. | PAYABLES: AMOUNTS FALLING DUE AFTER ONE YEAR |

2024 | 2023 |

£ | £ |

| Bank loans (see note 9) | 100,000 |  | - |  |

9. | LOANS

| An analysis of the maturity of loans is given below:

2024 | 2023 |

£ | £ |

| Amounts falling due within one year or on demand:

| Bank loans | 40,000 |  | 62,500 |  |

| Amounts falling due between one and two years:

| Bank loans - 1-2 years | 40,000 |  | - |  |

| Amounts falling due between two and five years:

| Bank loans - 2-5 years | 60,000 |  | - |  |

| Bank loans and overdrafts are secured by fixed and floating charges on the asset of the company.

10. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2024 | 2023 |

| value: | £ | £ |

| 4 | Ordinary shares | 1 | 4 |  | 4 |  |

11. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

| The Auditors' Report was unqualified.

| Mr. Ryan Falls (F.C.A) (Senior Statutory Auditor)

| for and on behalf of Cooper Parry Audit (Ireland) Limited

CRAWSHAW HALL HEALTHCARE LIMITED (REGISTERED NUMBER: 07983476)

Notes to the Financial Statements - continued

for the Year Ended 30 November 2024

12. | RELATED PARTY DISCLOSURES

| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose transactions with group companies.

| The following transactions occurred with related parties:

|  | 2024 |  | 2023 |  |

| Amounts due from/(to) related parties: |  | £ |  | £ |  |

| Constantia Healthcare Group Limited |  | 1,285,406 |  | 894,297 |  |

| Longlands Care Home (Middlesbrough) Limited |  | (48,295 | ) | (58,741 | ) |

| Fern Holdings Limited |  | 38,489 |  | 2,979 |  |

| CHI (Linson Court) Limited |  | (73,333 | ) | 2,167 |  |

| CHI (Manorcroft) Limited |  | (106,899 | ) | 2,167 |  |

| Middlesbrough Grange Care Home Ltd |  | (18,080 | ) | - |  |

| Constantia Healthcare Investments Ltd |  | 6,101 |  | 6,101 |  |

| AMNK Ltd |  | - |  | (590,358 | ) |

|  | 1,083,389 |  | 258,612 |  |

| The above companies are deemed to be related parties given the shareholding of the entities. In the opinion of the directors these amounts arise in the ordinary course of business.

13. | ULTIMATE CONTROLLING PARTY

| The controlling party is the immediate and ultimate parent undertaking, Constantia Healthcare Investments (No.2) Limited .

| The results of the company are included in the consolidated financial statements of Constantia Healthcare Investments (No.2) Limited, which are available from the registered office at 491a Bradford Road, Batley, West Yorkshire, England, WF17 8LQ.